Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy

N. Hotta, R. Kawamori, M. Fukuda and Y. Shigeta

Diabetic Medicine 29 ( 12 ): 1529 - 1533 , 2012